Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older

dc.contributor.buuauthorKanat, Ozkan
dc.contributor.buuauthorEvrensel, Türkkan
dc.contributor.buuauthorDemiray, Mutlu
dc.contributor.buuauthorKurt, Ender
dc.contributor.buuauthorGönüllü, Güzin
dc.contributor.buuauthorArslan, Murat
dc.contributor.buuauthorManavoǧlu, Osman
dc.contributor.buuauthorÖzkan, Hasan Atilla
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-2501-3097tr_TR
dc.contributor.orcid0000-0002-9732-5340tr_TR
dc.contributor.researcheridM-8060-2019tr_TR
dc.contributor.researcheridAAJ-1027-2021tr_TR
dc.contributor.scopusid55881548500tr_TR
dc.contributor.scopusid6603942124tr_TR
dc.contributor.scopusid6603631569tr_TR
dc.contributor.scopusid7006207332tr_TR
dc.contributor.scopusid6506410014tr_TR
dc.contributor.scopusid57197925370tr_TR
dc.contributor.scopusid6602587152tr_TR
dc.contributor.scopusid9250698600tr_TR
dc.date.accessioned2023-11-22T08:43:01Z
dc.date.available2023-11-22T08:43:01Z
dc.date.issued2003-08-01
dc.identifier.citationKanat, O. vd. (2003). “Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older”. Lung Cancer, 41(2), 233-234.en_US
dc.identifier.endpage234tr_TR
dc.identifier.issn0169-5002
dc.identifier.issue2tr_TR
dc.identifier.pubmed12871788tr_TR
dc.identifier.scopus2-s2.0-0037829153tr_TR
dc.identifier.startpage233tr_TR
dc.identifier.urihttps://doi.org/10.1016/S0169-5002(03)00199-5
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0169500203001995
dc.identifier.urihttp://hdl.handle.net/11452/34974
dc.identifier.volume41tr_TR
dc.identifier.wos000184525600014tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.journalLung Canceren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOncologyen_US
dc.subjectRespiratory systemen_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeAnemiaen_US
dc.subject.emtreeBone marrowen_US
dc.subject.emtreeBrain metastasisen_US
dc.subject.emtreeCancer chemotherapyen_US
dc.subject.emtreeCancer survivalen_US
dc.subject.emtreeChemoprophylaxisen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical practiceen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeDisease courseen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGeriatricsen_US
dc.subject.emtreeHeart functionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeHydrationen_US
dc.subject.emtreeKidney functionen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeLiver functionen_US
dc.subject.emtreeLung non small cell canceren_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreeNephrotoxicityen_US
dc.subject.emtreeNeuropathytr_TR
dc.subject.emtreeNeutropeniaen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeThorax radiographyen_US
dc.subject.emtreeThrombocytopeniaen_US
dc.subject.emtreeToxicityen_US
dc.subject.emtreeVomitingen_US
dc.subject.emtreeAntiemetic agenten_US
dc.subject.emtreeCisplatinen_US
dc.subject.emtreeDexamethasoneen_US
dc.subject.emtreeEtoposideen_US
dc.subject.emtreeInfusion fluiden_US
dc.subject.emtreeMannitolen_US
dc.subject.emtreeSerotonin 3 antagonisten_US
dc.subject.wosOncologyen_US
dc.subject.wosRespiratory systemen_US
dc.titleCisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or olderen_US
dc.typeLetter

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: